Alain P. Gobert

The Novel Melatonin Agonist Agomelatine (S20098) Is an Antagonist at 5-Hydroxytryptamine2C Receptors, Blockade of Which Enhances the Activity of Frontocortical Dopaminergic and Adrenergic Pathways

Mark J. Millan, Alain P. Gobert, F. Lejeune et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 509 citations · Full text

<i>Helicobacter pylori</i>arginase inhibits nitric oxide production by eukaryotic cells: A strategy for bacterial survival

Alain P. Gobert, David J. McGee, Mahmood Akhtar et al. · Proceedings of the National Academy of Sciences · 2001 · 373 citations · Full text

Serotonin2C receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: A combined dialysis and electrophysiological analysis in the rat

Alain P. Gobert, Jean‐Michel Rivet, F. Lejeune et al. · Synapse · 2000 · 335 citations

Psychopharmacology, Antagonist Mdl100,907, Social Sciences +19

(1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.

Robert D. Schreiber, Mauricette Brocco, Valérie Audinot et al. · Journal of Pharmacology and Experimental Therapeutics · 1995 · 295 citations

Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo

Mark J. Millan, Anne Dekeyne, Alain P. Gobert · Neuropharmacology · 1998 · 282 citations

Neuropsychology, Neurophysiology, Medicine +11